These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 37047172)

  • 41. Antibiotic-free nanotherapeutics: ultra-small, mucus-penetrating solid lipid nanoparticles enhance the pulmonary delivery and anti-virulence efficacy of novel quorum sensing inhibitors.
    Nafee N; Husari A; Maurer CK; Lu C; de Rossi C; Steinbach A; Hartmann RW; Lehr CM; Schneider M
    J Control Release; 2014 Oct; 192():131-40. PubMed ID: 24997276
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhanced permeability of blood-brain barrier and targeting function of brain via borneol-modified chemically solid lipid nanoparticle.
    Song H; Wei M; Zhang N; Li H; Tan X; Zhang Y; Zheng W
    Int J Nanomedicine; 2018; 13():1869-1879. PubMed ID: 29636606
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hierarchically targetable polysaccharide-coated solid lipid nanoparticles as an oral chemo/thermotherapy delivery system for local treatment of colon cancer.
    Shen MY; Liu TI; Yu TW; Kv R; Chiang WH; Tsai YC; Chen HH; Lin SC; Chiu HC
    Biomaterials; 2019 Mar; 197():86-100. PubMed ID: 30641267
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vitamin B12-loaded solid lipid nanoparticles as a drug carrier in cancer therapy.
    Genç L; Kutlu HM; Güney G
    Pharm Dev Technol; 2015 May; 20(3):337-44. PubMed ID: 24344935
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Solid lipid nanoparticles and nanostructured lipid carriers: a review of the methods of manufacture and routes of administration.
    Akbari J; Saeedi M; Ahmadi F; Hashemi SMH; Babaei A; Yaddollahi S; Rostamkalaei SS; Asare-Addo K; Nokhodchi A
    Pharm Dev Technol; 2022 Jun; 27(5):525-544. PubMed ID: 35635506
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chapter 6 - Solid lipid nanoparticle formulations pharmacokinetic and biopharmaceutical aspects in drug delivery.
    Souto EB; Doktorovová S
    Methods Enzymol; 2009; 464():105-29. PubMed ID: 19903552
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Absorption, disposition and pharmacokinetics of solid lipid nanoparticles.
    Qi J; Lu Y; Wu W
    Curr Drug Metab; 2012 May; 13(4):418-28. PubMed ID: 22443536
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lipid Nanocarrier: an Efficient Approach Towards Ocular Delivery of Hydrophilic Drug (Valacyclovir).
    Kumar R; Sinha VR
    AAPS PharmSciTech; 2017 Apr; 18(3):884-894. PubMed ID: 27368921
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cholesteryl oleate-loaded cationic solid lipid nanoparticles as carriers for efficient gene-silencing therapy.
    Suñé-Pou M; Prieto-Sánchez S; El Yousfi Y; Boyero-Corral S; Nardi-Ricart A; Nofrerias-Roig I; Pérez-Lozano P; García-Montoya E; Miñarro-Carmona M; Ticó JR; Suñé-Negre JM; Hernández-Munain C; Suñé C
    Int J Nanomedicine; 2018; 13():3223-3233. PubMed ID: 29881274
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles.
    Elnaggar YS; El-Massik MA; Abdallah OY
    Int J Nanomedicine; 2011; 6():3195-205. PubMed ID: 22238508
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug.
    Jain A; Agarwal A; Majumder S; Lariya N; Khaya A; Agrawal H; Majumdar S; Agrawal GP
    J Control Release; 2010 Dec; 148(3):359-67. PubMed ID: 20854859
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lipid nanoparticles for chemotherapeutic applications: strategies to improve anticancer efficacy.
    Lin X; Gao R; Zhang Y; Qi N; Zhang Y; Zhang K; He H; Tang X
    Expert Opin Drug Deliv; 2012 Jul; 9(7):767-81. PubMed ID: 22554018
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methotrexate-loaded SLNs prepared by coacervation technique: in vitro cytotoxicity and in vivo pharmacokinetics and biodistribution.
    Battaglia L; Serpe L; Muntoni E; Zara G; Trotta M; Gallarate M
    Nanomedicine (Lond); 2011 Nov; 6(9):1561-73. PubMed ID: 22011315
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Solid lipid nanoparticles for hydrophilic drugs.
    Mirchandani Y; Patravale VB; S B
    J Control Release; 2021 Jul; 335():457-464. PubMed ID: 34048841
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recent progress of drug nanoformulations targeting to brain.
    Khan AR; Yang X; Fu M; Zhai G
    J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SLN, NLC, LDC: state of the art in drug and active delivery.
    Attama AA
    Recent Pat Drug Deliv Formul; 2011 Sep; 5(3):178-87. PubMed ID: 21834777
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Solid lipid nanoparticle-based dissolving microneedles: A promising intradermal lymph targeting drug delivery system with potential for enhanced treatment of lymphatic filariasis.
    Permana AD; Tekko IA; McCrudden MTC; Anjani QK; Ramadon D; McCarthy HO; Donnelly RF
    J Control Release; 2019 Dec; 316():34-52. PubMed ID: 31655132
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting of eugenol-loaded solid lipid nanoparticles to the epidermal layer of human skin.
    Garg A; Singh S
    Nanomedicine (Lond); 2014; 9(8):1223-38. PubMed ID: 23987096
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development and characterization of 5-FU bearing ferritin appended solid lipid nanoparticles for tumour targeting.
    Jain SK; Chaurasiya A; Gupta Y; Jain A; Dagur P; Joshi B; Katoch VM
    J Microencapsul; 2008 Aug; 25(5):289-97. PubMed ID: 18608808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.